Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENTROPY NEURODYNAMICS LIMITED Director's Dealing 2023

Jun 21, 2023

64855_rns_2023-06-21_d2a46749-64fb-479c-8477-21fafb6fae94.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director's Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity Exopharm Limited
ABN 78 163 765 991

We (the entity) give ASX the following information under listing rule 3.19.A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Jason Watson
Date of last notice 28 April 2023
Date that director ceased to be 22 June 2023
director

Part 1 - Director's relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Number & class of securities

Nil

Part 2 - Director's relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of Securities
interest
Note: Provide details of the circumstances
giving rise to the relevant interest.
WATSON PRACTICE COMPANY 760,000 - ORDINARY FULLY PAID SHARES
PTY LTD
<WATSON PRACTICE A/C>
(Watson Practice Company Pty Ltd
<Watson Practice A/C> (Director
and Controller))

Part 3 - Director's interests in contracts

Detail of contract Nil

  • See chapter 19 for defined terms.

11/03/2002

Appendix 3Z Page 1

Appendix 3Z Final Director's Interest Notice

Nature of interest Nil
Name of registered holder (ifissued securities) Nil
No. and class of securities towhich interest relates Nil
  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/03/2002